Skip to main content
. 2017 Jul 17;9:79–86. doi: 10.2147/CPAA.S140057

Figure 1.

Figure 1

Imunohistochemical staining of pancreatic cancers (×20) from three patients with positive staining of tumors with GluN2B antibodies (left panels) and negative controls of GluN2B antibodies in the presence of excess peptide antigen (right panels).

Note: Two included normal pancreatic tissues, that give no staining with GluN2B antibodies (last two panels).